The pathogenesis of Burkitt's lymphoma.
Magrath
I
I
Lymphoma Biology Section, National Cancer Institute, Bethesda, Maryland 20892.
D000818:Animals; D001402:B-Lymphocytes / Q000473:pathology; D002051:Burkitt Lymphoma / Q000453:epidemiology / Q000209:etiology* / Q000235:genetics / Q000276:immunology / Q000473:pathology; D002645:Chickens; D002883:Chromosomes, Human, Pair 14 / Q000648:ultrastructure; D002889:Chromosomes, Human, Pair 2 / Q000648:ultrastructure; D002892:Chromosomes, Human, Pair 22 / Q000648:ultrastructure; D003043:Cocarcinogenesis; D004195:Disease Models, Animal; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D014943:Global Health; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000502:physiology; D006801:Humans; D007136:Immunoglobulins / Q000235:genetics; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D008297:Male; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology; D009857:Oncogenes; D011323:Primates; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology; D016271:Proto-Oncogene Proteins c-myc; D051381:Rats; D014178:Translocation, Genetic; D014412:Tumor Virus Infections / Q000150:complications
D007136:Immunoglobulins; D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins; D016271:Proto-Oncogene Proteins c-myc